BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAD4. A total of 36 filers reported holding BRIDGEBIO PHARMA INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9,265,350 | -27.9% | 15,000,000 | -25.0% | 0.17% | -33.3% |
| Q1 2023 | $12,853,200 | +2.0% | 20,000,000 | -33.3% | 0.25% | +4.6% |
| Q4 2022 | $12,600,000 | +0.7% | 30,000,000 | 0.0% | 0.24% | +3.9% |
| Q3 2022 | $12,509,000 | +3.0% | 30,000,000 | 0.0% | 0.23% | +5.5% |
| Q2 2022 | $12,150,000 | -15.7% | 30,000,000 | 0.0% | 0.22% | -6.0% |
| Q1 2022 | $14,416,000 | – | 30,000,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INHERENT GROUP, LP | 39,500,000 | $15,386,396 | 4.59% |
| Athyrium Capital Management, LP | 20,000,000 | $7,753,900 | 3.26% |
| Diameter Capital Partners LP | 43,287,000 | $16,786,915 | 2.61% |
| Affinity Asset Advisors, LLC | 10,000,000 | $3,895,290 | 1.53% |
| DeepCurrents Investment Group LLC | 39,355,000 | $14,590,746 | 0.57% |
| BRAIDWELL LP | 42,294,000 | $16,151,021 | 0.54% |
| Context Capital Management, LLC | 16,458 | $6,285 | 0.46% |
| Aequim Alternative Investments LP | 31,000,000 | $11,838,125 | 0.32% |
| ARISTEIA CAPITAL, L.L.C. | 40,816,000 | $15,586,610 | 0.31% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 5,000,000 | $1,875,000 | 0.28% |